Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck ROE 2010-2024 | MKKGY

Current and historical return on equity (ROE) values for Merck (MKKGY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Merck ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $3.01B $32.45B 9.62%
2024-09-30 $2.93B $31.22B 9.64%
2024-06-30 $2.84B $30.82B 9.39%
2024-03-31 $2.96B $30.48B 9.90%
2023-12-31 $3.06B $28.96B 10.44%
2023-09-30 $3.09B $30.80B 10.70%
2023-06-30 $3.22B $29.19B 11.36%
2023-03-31 $3.37B $28.16B 12.06%
2022-12-31 $3.51B $27.40B 12.81%
2022-09-30 $3.76B $28.54B 14.01%
2022-06-30 $3.73B $27.70B 14.44%
2022-03-31 $3.70B $25.80B 14.98%
2021-12-31 $3.62B $25.34B 15.07%
2021-09-30 $3.20B $24.39B 14.23%
2021-06-30 $3.25B $23.33B 14.98%
2021-03-31 $2.67B $22.89B 12.82%
2020-12-31 $2.27B $19.44B 11.23%
2020-09-30 $2.12B $21.04B 10.39%
2020-06-30 $1.56B $19.85B 7.72%
2020-03-31 $1.77B $20.52B 8.77%
2019-12-31 $1.48B $20.06B 7.38%
2019-09-30 $4.00B $20.22B 19.91%
2019-06-30 $4.02B $19.75B 20.58%
2019-03-31 $3.78B $20.08B 19.89%
2018-12-31 $3.99B $20.35B 21.75%
2018-09-30 $2.27B $17.84B 13.20%
2018-06-30 $2.63B $17.76B 15.68%
2018-03-31 $2.80B $17.34B 17.35%
2017-12-31 $2.94B $15.90B 18.75%
2017-09-30 $2.06B $16.21B 13.25%
2017-06-30 $1.82B $15.14B 11.98%
2017-03-31 $1.71B $15.43B 11.37%
2016-12-31 $1.80B $15.55B 12.34%
2016-09-30 $1.65B $14.50B 11.56%
2016-06-30 $1.55B $14.52B 10.64%
2016-03-31 $1.58B $13.86B 10.67%
2015-12-31 $1.25B $14.27B 8.19%
2015-09-30 $1.42B $15.60B 9.13%
2015-06-30 $1.35B $15.38B 8.63%
2015-03-31 $1.37B $15.60B 8.79%
2014-12-31 $1.50B $15.69B 9.63%
2014-09-30 $1.56B $15.64B 10.23%
2014-06-30 $1.68B $15.39B 11.26%
2014-03-31 $1.70B $15.41B 11.67%
2013-12-31 $1.60B $14.70B 11.27%
2013-09-30 $1.56B $14.28B 11.31%
2013-06-30 $1.35B $13.76B 9.92%
2013-03-31 $0.85B $13.89B 6.28%
2012-12-31 $0.73B $13.39B 7.23%
2012-09-30 $0.55B $13.22B 5.36%
2012-06-30 $0.64B $13.54B 9.14%
2012-03-31 $0.60B 8.09%
2011-12-31 $0.84B $14.62B 11.40%
2011-09-30 $0.75B 20.19%
2011-06-30 $0.70B $14.90B 9.87%
2011-03-31 $1.05B 30.94%
2010-12-31 $0.84B 24.73%
2010-09-30 $0.83B $13.59B 24.53%
2010-06-30 $0.77B 0.00%
2010-03-31 $0.69B 0.00%
2009-12-31 $0.51B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.157B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.493B 31.32
Zoetis (ZTS) United States $71.874B 26.82
Daiichi Sankyo, - (DSNKY) Japan $49.349B 25.11
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
Sandoz Group AG (SDZNY) Switzerland $21.424B 0.00
Summit Therapeutics (SMMT) United States $18.871B 0.00
United Therapeutics (UTHR) United States $13.969B 12.36
Shionogi (SGIOY) Japan $13.560B 13.59
Neurocrine Biosciences (NBIX) United States $11.931B 40.87
IPSEN (IPSEY) France $9.964B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.038B 65.35
Stevanato Group S.p.A (STVN) Italy $7.265B 44.43
Madrigal Pharmaceuticals (MDGL) United States $6.156B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.631B 0.00
Ionis Pharmaceuticals (IONS) United States $5.332B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.694B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.966B 10.39
Crinetics Pharmaceuticals (CRNX) United States $2.804B 0.00
Hypermarcas (HYPMY) Brazil $2.702B 17.77
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.279B 12.32
BioCryst Pharmaceuticals (BCRX) United States $2.107B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.713B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.665B 0.00
Indivior (INDV) United States $1.557B 6.60
Evotec AG (EVO) Germany $1.424B 0.00
ARS Pharmaceuticals (SPRY) United States $1.397B 0.00
Guardian Pharmacy Services (GRDN) United States $1.396B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 22.54
Harrow (HROW) United States $0.981B 0.00
Ardelyx (ARDX) United States $0.955B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.885B 0.00
Enliven Therapeutics (ELVN) United States $0.831B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.769B 0.00
Akebia Therapeutics (AKBA) United States $0.738B 0.00
AleAnna (ANNA) United States $0.680B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.05
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Xencor (XNCR) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Bioventus (BVS) United States $0.534B 13.54
Savara (SVRA) United States $0.503B 0.00
Relay Therapeutics (RLAY) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Altimmune (ALT) United States $0.453B 0.00
CytoDyn (CYDY) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.438B 9.15
Oruka Therapeutics (ORKA) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 10.12
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.52
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.225B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.208B 0.00
OmniAb (OABI) United States $0.175B 0.00
Avita Medical (RCEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Esperion Therapeutics (ESPR) United States $0.169B 0.00
4D Molecular Therapeutics (FDMT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Wellgistics Health (WGRX) United States $0.162B 0.00
Liminatus Pharma (LIMN) $0.160B 0.00
Journey Medical (DERM) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Aclaris Therapeutics (ACRS) United States $0.140B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aldeyra Therapeutics (ALDX) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Larimar Therapeutics (LRMR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
VAXART, INC (VXRT) United States $0.104B 0.00
Lexeo Therapeutics (LXEO) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Surrozen (SRZN) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00